Vonoprazan and amoxicillin dual therapy as the first‐line treatment of <i>Helicobacter pylori</i> infection: A systematic review and meta‐analysis
2023 · Helicobacter · 36 citations
https://doi.org/10.1111/hel.13039
Y
Yaobin Ouyang
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.5K
Citations
22
h-index
27
i10-index
Yaobin Ouyang is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Helicobacter pylori-related gastroenterology studies & Gastric Cancer Management and Outcomes & Gut microbiota and health. The author has an h-index of 22, co-authored 45 publications.
ORCID: 0000-0002-0248-1907Papers by this author
worksSingle-cell transcriptomic profiling uncovers cellular complexity and microenvironment in gastric tumorigenesis associated with Helicobacter pylori
2024 · Journal of Advanced Research · 26 citations
https://doi.org/10.1016/j.jare.2024.10.012
Sex-specific effects of gastrointestinal microbiome disruptions on Helicobacter pylori-induced gastric carcinogenesis in INS-GAS mice
2025 · Biology of Sex Differences · 4 citations
https://doi.org/10.1186/s13293-025-00700-z
1259 DDIT4 PREVENTS HELICOBACTER PYLORI-INDUCED GASTRIC METAPLASIA THROUGH METABOLIC REGULATION OF FERROPTOSIS
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)01166-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat